Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Condition(s):Carcinomas (Including Squamous Cell and Adenocarcinoma); NeoplasmsLast Updated:January 17, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Carcinomas (Including Squamous Cell and Adenocarcinoma); NeoplasmsLast Updated:January 17, 2024Recruiting
Condition(s):Radiation Cystitis; Prostate Cancer; Radiotherapy Side EffectLast Updated:April 28, 2023Recruiting
Condition(s):Dry Age-related Macular Degeneration; Geographic Atrophy; Retinal Disease; Macular Degeneration; Macular Atrophy; Retinal Degeneration; Eye DiseasesLast Updated:October 13, 2023Recruiting
Condition(s):Acute Febrile Illness; Use of Antimicrobial Agents; C-reactive Protein LevelLast Updated:June 23, 2023Recruiting
Condition(s):Alzheimer Disease, Early Onset; Protein; DiseaseLast Updated:November 15, 2022Recruiting
Condition(s):Acute Liver Failure; Acute Liver Injury; Acute on Chronic Hepatic FailureLast Updated:August 30, 2016Not yet recruiting
Condition(s):Anterior Cruciate Ligament InjuriesLast Updated:September 21, 2023Recruiting
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:February 7, 2024Recruiting
Condition(s):Atrial FibrillationLast Updated:May 9, 2023Recruiting
Condition(s):PrediabetesLast Updated:March 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.